Key facts
- This page summarizes Abraham N. Oler's Form 4 filing for Onconova Therapeutics, Inc. (TRAW).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 Jan 2022, 08:12.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Additional SEC filing notes
Footnote F1
The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Footnote F2
Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee.